Area of research
Rheumatology · Physiology
Research interest
Research interests include Systemic Lupus Erythematosus Research, Salivary Gland Disorders and Functions, Diabetes and associated disorders, and Rheumatoid Arthritis Research and Therapies.
Diagnostic Performance of Anti-dsDNA Tests by Indirect Immunofluorescence and Enzyme-linked Immunosorbent Assay in Patients with Systemic Lupus Erythematosus.
B-cell activating factor (BAFF) and its receptors' expression in pediatric nephrotic syndrome is associated with worse prognosis.
Increase in direct costs for health systems due to lupus nephritis: the case of Colombia.
Association of Antiribosomal P Antibody with Neurological and Systemic Manifestations in Patients with Systemic Lupus Erythematosus in Southwestern Colombia.
Rheumatological diseases in patients with primary hyperparathyroidism.
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group
Systemic erythematosus lupus and pregnancy outcomes in a Colombian cohort.
Lymphomagenesis predictors and related pathogenesis.
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.
Reproducibility of minor salivary gland biopsy reports in Sjögren's syndrome and its correlation with disease biomarkers.
Systemic lupus erythematosus in the intensive care unit: a systematic review.
Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease.
Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases.
Clinical characterization, outcomes, and prognosis in patients with systemic lupus erythematosus admitted to the intensive care unit.
Therapeutic Plasma Exchange as Management of Complicated Systemic Lupus Erythematosus and Other Autoimmune Diseases.
Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.
Mortality in patients with systemic lupus erythematosus in Colombia: a case series.
Direct cost of lupus care in the developing world: the case of Colombia.
Correction to: Mortality in patients with systemic lupus erythematosus in Colombia: a case series.
Pentraxin 3 is useful to differentiate infections from flares in patients with systemic lupus erythematosus who present systemic inflammatory response.
Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort